NANETS/SNMMI procedure standard for somatostatin receptor–based peptide receptor radionuclide therapy with 177Lu-DOTATATE
…, L Gardner, WS Graham, S Lindsay… - Journal of Nuclear …, 2019 - Soc Nuclear Med
With the recent approval of 177 Lu-DOTATATE for use in gastroenteropancreatic neuroendocrine
tumors, access to peptide receptor radionuclide therapy is increasing. Representatives …
tumors, access to peptide receptor radionuclide therapy is increasing. Representatives …
A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer
…, KA Woeber, OH Clark, FS Greenspan, S Lindsay… - Surgery, 2006 - Elsevier
BACKGROUND: Rosiglitazone is a peroxisome proliferator-activated receptor gamma (PPARγ)
agonist that has been shown to induce differentiation, cell cycle arrest, and apoptosis in …
agonist that has been shown to induce differentiation, cell cycle arrest, and apoptosis in …
Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer
E Kebebew, S Lindsay, OH Clark, KA Woeber… - Thyroid, 2009 - liebertpub.com
Background: Rosiglitazone is a peroxisome proliferator–activated receptor (PPAR) gamma
agonist that has shown promise as both an antiproliferative and redifferentiating agent for the …
agonist that has shown promise as both an antiproliferative and redifferentiating agent for the …
Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results?
DM Elaraj, RS Sippel, S Lindsay, I Sansano… - Archives of …, 2010 - jamanetwork.com
Hypothesis Additional imaging studies are useful to select patients who are candidates for
minimally invasive parathyroidectomy, and referral is not indicated when results from a …
minimally invasive parathyroidectomy, and referral is not indicated when results from a …
Waiting for change: symptom resolution after adrenalectomy for Cushing's syndrome
RS Sippel, DM Elaraj, E Kebebew, S Lindsay… - Surgery, 2008 - Elsevier
BACKGROUND: The debilitating symptoms and physical changes from Cushing's syndrome
may resolve after treatment, but the time course to resolution is not well established. …
may resolve after treatment, but the time course to resolution is not well established. …
Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.
…, AH Ko, KP Kolli, M Kennedy, A Laffan, S Lindsay… - 2021 - ascopubs.org
77 Background: MSS mCRC rarely responds to pembrolizumab monotherapy, but capecitabine
and bevacizumab may induce immune-stimulatory effects. This study evaluates the …
and bevacizumab may induce immune-stimulatory effects. This study evaluates the …
Intraarterial peptide receptor radionuclide therapy using 90Y-DOTATOC for hepatic metastases of neuroendocrine tumors
…, S Jivan, E Armstrong, L Zhang, S Lindsay… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Given the high frequency of liver metastases in neuroendocrine tumor patients, we aimed to
determine whether hepatic intraarterial administration of 90 Y-DOTATOC peptide receptor …
determine whether hepatic intraarterial administration of 90 Y-DOTATOC peptide receptor …
The determination of specific characters for the identification of certain ascidians
ST Lindsay, H Thompson - … of the Marine Biological Association of …, 1930 - cambridge.org
In the course of a study involving the routine identification of Tunicata the need became
apparent of an attempt being made to define more clearly than has been done the diagnostic …
apparent of an attempt being made to define more clearly than has been done the diagnostic …
The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy
…, C Lawhn-Heath, A Paciorek, S Lindsay… - Journal of Nuclear …, 2024 - Soc Nuclear Med
Posttreatment imaging of γ-emissions after peptide receptor radionuclide therapy (PRRT)
can be used to perform quantitative dosimetry as well as assessment response using …
can be used to perform quantitative dosimetry as well as assessment response using …
Neonatal barbiturate withdrawal
I Blumenthal, S Lindsay - Postgraduate medical journal, 1977 - academic.oup.com
An infant with neonatal barbiturate withdrawal syndrome is reported. The clinical features,
diagnosis and treatment of this condition are discussed. A retrospective review of fifty-three …
diagnosis and treatment of this condition are discussed. A retrospective review of fifty-three …